Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Friday, February 20, 2015

Canada: New Hepatitis C drug Sovaldi needed in B.C., say desperate patients

Hepatitis C patients in B.C. are fighting to get access to new drug Sovaldi, which could cure them, but could also cost the provincial government up to $2.75 billion.

There are currently up to 25,000 British Columbians living with the contagious liver disease, which begins as a mild viral infection lasting a few weeks but can lead to a chronic, lifelong illness.

Desmond McKilligan of Kaslo, B.C., who contracted hepatitis C after receiving tainted blood 45 years ago, says going through life with the virus is exhausting.

Read more...

No comments:

Post a Comment